Valuation GlaxoSmithKline plc LIQUIDNET SYSTEMS

Stocks

Delayed LIQUIDNET SYSTEMS Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-0.40%	-

06-18	Moderna Secures Favorable FDA Panel Recommendation for mRNA Flu Vaccine
06-18	The Gulf Gives, the Fed Takes

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	76,765	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	4.87%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	91,764	88,700	85,609
Change	-	-24.65%	-1.89%	-8.24%	28.83%	4.69%	-3.34%	-3.48%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	12.3x	11.4x	11.1x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.45x	3.71x	3.19x
PEG	-	0x	-0.2x	-0.4x	0x	1.2x	1.43x	4.29x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.27x	2.16x	2.1x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.72x	2.5x	2.34x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	7.99x	7.22x	6.84x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.01x	8.09x	7.49x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	15.4x	13.9x	13.6x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.49%	7.18%	7.36%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.7201	0.7614	0.763
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.74%	3.96%	3.97%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.558	1.682	1.725
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	46.2%	45.3%	44.2%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,794	35,477	36,579
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,481	12,281	12,525
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,181	10,967	11,432
Net income ¹	4,385	14,956	4,928	2,575	5,716	6,266	6,669	6,902
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	14,999	11,935	8,844
Reference price ²	20.08	14.38	14.50	13.46	18.24	19.23	19.23	19.23
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	3,991,951	-	-
Announcement Date	09/02/22	01/02/23	31/01/24	05/02/25	04/02/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	32.14x	11.69x	24.07x	0.62%	980B
JOHNSON & JOHNSON	24.41x	5.63x	15.32x	2.34%	550B
ABBVIE INC.	26.86x	6.49x	13.28x	3.17%	382B
ROCHE HOLDING AG	17x	4.23x	10.41x	3.14%	317B
ASTRAZENECA PLC	21.82x	4.57x	12.95x	1.92%	270B
NOVARTIS AG	20.35x	5.28x	12.82x	3.05%	269B
NOVO NORDISK A/S	12.43x	4.64x	9.55x	4.05%	191B
AMGEN INC.	21.95x	5.91x	10.33x	2.99%	182B
GILEAD SCIENCES, INC.	-44.34x	5.36x	29.54x	2.62%	154B
Average	14.73x	5.98x	15.36x	2.65%	366B
Weighted average by Cap.	21.70x	7.23x	16.87x	2.17%